{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:20:12Z","timestamp":1773829212959,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1016\/s0014-2999(97)01442-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T13:49:30Z","timestamp":1027604970000},"page":"39-44","source":"Crossref","is-referenced-by-count":273,"title":["Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors"],"prefix":"10.1016","volume":"341","author":[{"given":"GianLuigi","family":"Gessa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Melis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AnnaLisa","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Diana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0014-2999(97)01442-8_BIB1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0006-8993(95)00645-7","article-title":"The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway","volume":"691","author":"Anderson","year":"1995","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/S0014-2999(97)01442-8_BIB2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0091-3057(91)90367-B","article-title":"THC does not affect striatal dopamine release: Microdialysis in freely moving rats","volume":"40","author":"Casta\u00f1eda","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/jm00079a016","article-title":"Conformationally restrained analogues of pravadoline: Nanomolar potent, enantioselective, (aminoalkyl) indole agonists of the cannabinoid receptor","volume":"35","author":"D'ambra","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB4","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB5","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"2","key":"10.1016\/S0014-2999(97)01442-8_BIB6","first-page":"151","article-title":"Cannabinoid pharmacology","volume":"38","author":"Dewey","year":"1986","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF00247365","article-title":"Electrophysiological analysis of dopamine cells from the substantia nigra pars compacta of circling rats","volume":"74","author":"Diana","year":"1989","journal-title":"Exp. Brain Res."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB8","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"94","author":"Di Chiara","year":"1988","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1523\/JNEUROSCI.08-01-00100.1988","article-title":"Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Studies in the ventral tegmental area","volume":"8","author":"Einhorn","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(97)00278-4","article-title":"\u03949-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors","volume":"226","author":"French","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00001756-199702100-00014","article-title":"Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra","volume":"8","author":"French","year":"1997","journal-title":"NeuroReport"},{"issue":"3","key":"10.1016\/S0014-2999(97)01442-8_BIB12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0091-3057(91)90365-9","article-title":"Marijuana's interaction with brain reward systems: Update 1991","volume":"40","author":"Gardner","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02431546","article-title":"Facilitation of brain stimulation reward by \u03949-tetrahydrocannabinol","volume":"96","author":"Gardner","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00001756-199507100-00015","article-title":"The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat","volume":"6","author":"Gueudet","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(91)90970-7","article-title":"Neuronal localization of cannabinoid receptors in the basal ganglia of the rat brain","volume":"547","author":"Herkenham","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB17","doi-asserted-by":"crossref","unstructured":"Johnson, M.R., Melvin, L.S., 1986. The discovery of non classical cannabinoid analgetics. In: Cannabinoids as Therapeutic Agents. CRC Press, Boca Raton, pp. 121\u2013145.","DOI":"10.1201\/9780429260667-7"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/syn.890030105","article-title":"Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration","volume":"3","author":"Kelland","year":"1989","journal-title":"Synapse"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/syn.890060213","article-title":"Anesthetic influence on the basal activity and pharmacologically responsiveness of nigrostriatal dopamine neurons","volume":"6","author":"Kelland","year":"1990","journal-title":"Synapse"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(81)90015-7","article-title":"Antidromic activation of neurones as an analytic tool in the study of the central nervous system","volume":"4","author":"Lipsky","year":"1981","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0306-4522(84)90048-4","article-title":"Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine","volume":"11","author":"Matthews","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00008877-199605001-00154","article-title":"The cannabinoid receptor agonist WIN 55,212-2 potently stimulates dopaminergic neuronal activity in the mesolimbic system","volume":"7 (Suppl. 1)","author":"Melis","year":"1996","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0006-8993(84)90890-4","article-title":"Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats","volume":"292","author":"Mereu","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB25","unstructured":"Mereu, G., Fanni, B., Gessa, G.L., 1984. General anesthetics prevent dopaminergic neuron stimulation by neuroleptics. In: Usdin, E., Carlsson, A., Dahlstr\u00f6m, A., Engel, J. (Eds.), Cathecolamines, Part B: Neuropharmacology and Central Nervous System \u2013 Theoretical Aspects. Alan R. Liss, Inc., New York, pp. 353-358."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0014-2999(87)90556-5","article-title":"Preferential stimulation of ventral tegmental dopaminergic neurons by nicotine","volume":"141","author":"Mereu","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0014-2999(97)01442-8_BIB28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-8993(88)90749-4","article-title":"Effects of \u03949-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: An in vivo electrochemical and in vivo microdialysis study","volume":"451","author":"Ng Cheong Ton","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB29","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/0024-3205(95)00175-6","article-title":"AM630, a competitive cannabinoid receptor antagonist","volume":"56","author":"Pertwee","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB30","first-page":"63","article-title":"Effect of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes","volume":"214","author":"Poddar","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/S0014-2999(97)01442-8_BIB32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0091-3057(89)90521-2","article-title":"\u03949-Tetrahydrocannabinol facilitates striatal dopaminergic transmission","volume":"33","author":"Sakurai Yamashita","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0014-2999(97)01442-8_BIB33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3940(96)12436-8","article-title":"Effects of intranigral cannabinoids on rotational behaviour in rats: Interactions with the dopaminergic system","volume":"206","author":"Sa\u00f1udo-Pe\u00f1a","year":"1996","journal-title":"Neurosci. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299997014428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299997014428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T13:11:52Z","timestamp":1579007512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299997014428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["S0014299997014428"],"URL":"https:\/\/doi.org\/10.1016\/s0014-2999(97)01442-8","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}